Literature DB >> 16954289

Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.

Nele Wellinghausen1, Beate Wirths, Sven Poppert.   

Abstract

Achromobacter xylosoxidans is frequently isolated from the respiratory secretions of cystic fibrosis (CF) patients, but identification with biochemical tests is unreliable. We describe fluorescence in situ hybridization assays for the rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis. Both assays showed high sensitivities and high specificities with a collection of 155 nonfermenters from CF patients.

Entities:  

Mesh：

Year:  2006        PMID： 16954289      PMCID： PMC1594702          DOI： 10.1128/JCM.00508-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  30 in total

1.  Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.

Authors:  M Hogardt; K Trebesius; A M Geiger; M Hornef; J Rosenecker; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 3.  Phylogenetic identification and in situ detection of individual microbial cells without cultivation.

Authors:  R I Amann; W Ludwig; K H Schleifer
Journal:  Microbiol Rev       Date:  1995-03

4.  Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

Authors:  L Saiman; Y Chen; S Tabibi; P San Gabriel; J Zhou; Z Liu; L Lai; S Whittier
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov.

Authors:  Tom Coenye; Johan Goris; Theodore Spilker; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans.

Authors:  S Tang; C C Cheng; K C Tse; F K Li; B Y Choy; T M Chan; K N Lai
Journal:  Am J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.754

7.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

8.  Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.

Authors:  D B Shelly; T Spilker; E J Gracely; T Coenye; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

10.  Alcaligenes infection in cystic fibrosis.

Authors:  Kenneth Tan; Steven P Conway; Keith G Brownlee; Christine Etherington; Daniel G Peckham
Journal:  Pediatr Pulmonol       Date:  2002-08
View more
  5 in total

1.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.

Authors:  Nicolas Degand; Etienne Carbonnelle; Brunhilde Dauphin; Jean-Luc Beretti; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Christine Segonds; Patrick Berche; Xavier Nassif; Agnès Ferroni
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

2.  Characterization of novel plant growth promoting endophytic bacterium Achromobacter xylosoxidans from wheat plant.

Authors:  Prabhat Jha; Ashok Kumar
Journal:  Microb Ecol       Date:  2009-02-18       Impact factor: 4.552

3.  A Tn5051-like mer-containing transposon identified in a heavy metal tolerant strain Achromobacter sp. AO22.

Authors:  Shee Ping Ng; Belinda Davis; Enzo A Palombo; Mrinal Bhave
Journal:  BMC Res Notes       Date:  2009-03-07

4.  Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes.

Authors:  Signe M Nielsen; Niels Nørskov-Lauritsen; Thomas Bjarnsholt; Rikke L Meyer
Journal:  Microorganisms       Date:  2016-09-14

5.  Exposing the Three-Dimensional Biogeography and Metabolic States of Pathogens in Cystic Fibrosis Sputum via Hydrogel Embedding, Clearing, and rRNA Labeling.

Authors:  William H DePas; Ruth Starwalt-Lee; Lindsey Van Sambeek; Sripriya Ravindra Kumar; Viviana Gradinaru; Dianne K Newman
Journal:  mBio       Date:  2016-09-27       Impact factor: 7.867
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.